Skip to main content
. 2015 Jan 21;21(3):926–934. doi: 10.3748/wjg.v21.i3.926

Table 4.

Association between mismatch repair/BRAF status and clinicopathological factors

MMR status (n = 208)
BRAF status (n = 211)
Variable pMMR dMMR P value Wild type Mutant P value
Gender
Female 87 16 0.800 94 11 0.844
Male 90 15 94 12
Age (yr)
≤ 50 24 6 0.397 29 1 0.151
> 50 153 25 159 22
Site
Right-sided 31 11 0.037a 36 7 0.510
Left-sided 59 12 67 6
Rectum 84 7 81 10
Synchronous lesions 3 1 4 0
Stage
I 25 7 0.053 30 2 0.552
II 55 8 58 7
III 68 16 73 12
IV 29 0 27 2
Invasion
No 99 17 0.910 106 12 0.701
LVI or PNI or both 78 14 82 11
Differentiation
Well-moderately 172 28 0.067 180 23 0.313
Poorly 5 3 8 0
Bowel wall invasion
pT1 3 1 0.511 4 0 0.410
pT2 34 9 39 5
pT3 126 18 128 18
pT4 14 3 17 0
Lymph node metastasis
pN- 88 15 0.891 96 9 0.280
pN+ 89 16 92 14
Distant metastasis
No 148 31 0.015a 161 21 0.456
Yes 29 0 21 2
a

P < 0.05 vs control. MMR: Mismatch repair; pT: Pathological tumor stage; pN: Pathological nodal stage; ALI: Angiolymphatic invasion; PNI: Perineural invasion.